• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during pregnancy and nursing is a challenge for women suffering from the condition. There is a lack of information about how long-term exposure to these medications could affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to evaluate the benefits of using it versus the risks for the foetus. Physicians don't have the data to give clear advice, but can provide information on the risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based case control study to examine the prevalence of major structural defects in infants born to mothers who used stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to make sure that the classification was correct and to minimize any bias.

However, the researchers' study had its limitations. The researchers were unable in the beginning to distinguish the effects of the medication from the disorder. This limitation makes it difficult to determine whether the small differences observed in the exposed groups result from medication use or confounding by comorbidities. Additionally the study did not study long-term offspring outcomes.

The study found that infants whose mothers took inattentive adhd medication medication during pregnancy were at a slightly higher risk of admission to the neonatal care unit (NICU) as compared to mothers who didn't take any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appear to be independent of the type of medication used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during early pregnancy could be offset by the greater benefit to both the mother and child from continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, where possible, assist them in developing strategies to improve their coping abilities that may minimize the effects of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the question of whether or not to stop treatment during pregnancy is a question that more and more physicians face. These decisions are usually taken without clear and authoritative evidence. Instead, doctors must weigh their own knowledge in conjunction with the experiences of other doctors, and the research on the topic.

Particularly, the subject of potential risks for the baby can be tricky. Many studies on this issue are based on observational data instead of controlled research and their findings are often contradictory. Furthermore, Most Popular Adhd Medication studies restrict their analysis to live births, which may underestimate severe teratogenic effects that result in abortion or termination of the pregnancy. The study presented in the journal club addresses these issues by analyzing the data from deceased and live births.

Conclusion Some studies have revealed a positive correlation between ADHD medications and certain birth defects however, other studies haven't shown such a relationship. The majority of studies show that there is a neutral, or somewhat negative, impact. Therefore, a careful risk/benefit analysis must be conducted in every case.

It isn't easy, but not impossible for women with ADHD to stop taking their medication. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. Additionally, the loss of medication can interfere with the ability to perform work-related tasks and safely drive which are essential aspects of daily life for many people with ADHD.

She recommends women who are unsure about whether to keep or discontinue medication due to their pregnancy, consider informing family members, friends and colleagues on the condition, its impact on daily functioning, and on the benefits of keeping the current treatment plan. It can also help a woman feel more confident in her decision. It is important to remember that certain medications can be absorbed through the placenta so if a woman decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the medication could be passed on to the baby.

Birth Defects Risk

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about what impact the medications could have on fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Researchers used two huge datasets to analyze over 4.3 million pregnancy and determine if stimulant medication use caused birth defects. Researchers found that while the overall risk is low, the first trimester adhd medication names exposure to medication was associated with slightly higher risk of certain heart defects, like ventriculoseptal defect.

The researchers of the study didn't discover any link between early use of medication and congenital anomalies like facial deformities or club feet. The results are in the same vein as previous studies that have shown the existence of a slight, but significant increase in the number of cardiac malformations among women who began taking ADHD medication before the time of pregnancy. The risk was higher in the later part of pregnancy, when many women are forced to stop taking their ADHD medication.

Women who took ADHD medications in the first trimester of their pregnancy were also more likely to have caesarean sections, a low Apgar score after delivery and a baby that required help breathing at birth. However the researchers of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have other medical issues that could have contributed to these findings.

Researchers hope their research will help doctors when they meet pregnant women. They advise that while the discussion of the risks and benefits is crucial however, the decision to stop or continue treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors warn that, even though stopping the medication is a possibility to consider, it is not advised due to the high prevalence of depression and other mental problems in women who are expecting or recently gave birth. Further, the research suggests that women who decide to stop taking their medications are more likely to experience a difficult time adapting to life without them after the birth of their baby.

Nursing

The responsibilities of a new mother can be overwhelming. Women who suffer from ADHD may face a lot of challenges when they must manage their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to a new routine. Therefore, many women elect to continue taking their ADHD medications throughout the course of pregnancy.

The risk to nursing infant is low because the majority of stimulant medication passes through breast milk in low amounts. However, the frequency of medication exposure to the infant can differ based on dosage, how often it is administered and the time of day it is administered. In addition, various drugs enter the infant's system via the gastrointestinal tract or through breast milk. The impact of these medications on a newborn's health is not completely understood.

Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the lack of research. This is a difficult decision for the mother, who must weigh the benefits of her medication against the risk to the embryo. Until more information is available, doctors should ask all pregnant patients about their experience with treating adhd without medication and whether they plan or are taking to take medication during the perinatal period.

A increasing number of studies have revealed that most women can safely continue taking their ADHD medication during pregnancy and breastfeeding. In response, a rising number of patients are opting to do this. They have discovered through consultation with their doctor that the benefits of retaining their current medication outweigh any possible risks.

Women who suffer from ADHD who are planning to breastfeed should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help women with ADHD recognize their symptoms and the underlying disorder and learn about treatment options and strengthen existing coping strategies. This should be a multidisciplinary approach with the GPs, obstetricians, and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, monitoring of indicators of deterioration, and, if necessary adjustments to the medication regimen.